Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 236

1.

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds.

Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME, Colagiuri S, Fulcher G, de Galan BE, Harrap S, Hamet P, Heller S, MacMahon S, Marre M, Poulter N, Travert F, Patel A, Neal B, Woodward M; ADVANCE Collaborative Group.

Diabetologia. 2012 Mar;55(3):636-43. doi: 10.1007/s00125-011-2404-1. Epub 2011 Dec 21.

PMID:
22186981
[PubMed - indexed for MEDLINE]
2.

Relationship between HbA1c and risk of all-cause hospital admissions among people with Type 2 diabetes.

Yu D, Simmons D.

Diabet Med. 2013 Dec;30(12):1407-11. doi: 10.1111/dme.12235. Epub 2013 Jun 19.

PMID:
23692400
[PubMed - indexed for MEDLINE]
3.

Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.

Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD.

Lancet. 2010 Feb 6;375(9713):481-9. doi: 10.1016/S0140-6736(09)61969-3. Epub 2010 Jan 26.

PMID:
20110121
[PubMed - indexed for MEDLINE]
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
5.

Glycaemic control and the risk of mortality in elderly type 2 diabetic patients (ZODIAC-20).

van Hateren KJ, Landman GW, Kleefstra N, Drion I, Groenier KH, Houweling ST, Bilo HJ.

Int J Clin Pract. 2011 Apr;65(4):415-9. doi: 10.1111/j.1742-1241.2010.02596.x.

PMID:
21401830
[PubMed - indexed for MEDLINE]
6.

Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.

Lind M, Bounias I, Olsson M, Gudbjörnsdottir S, Svensson AM, Rosengren A.

Lancet. 2011 Jul 9;378(9786):140-6. doi: 10.1016/S0140-6736(11)60471-6. Epub 2011 Jun 24.

PMID:
21705065
[PubMed - indexed for MEDLINE]
7.

The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.

Ma J, Yang W, Fang N, Zhu W, Wei M.

Nutr Metab Cardiovasc Dis. 2009 Nov;19(9):596-603. doi: 10.1016/j.numecd.2009.07.004. Epub 2009 Oct 9.

PMID:
19819121
[PubMed - indexed for MEDLINE]
8.

Comorbidity and glycemic control in patients with type 2 diabetes.

El-Kebbi IM, Ziemer DC, Cook CB, Miller CD, Gallina DL, Phillips LS.

Arch Intern Med. 2001 May 28;161(10):1295-300.

PMID:
11371257
[PubMed - indexed for MEDLINE]
9.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Patel A; ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B.

Lancet. 2007 Sep 8;370(9590):829-40.

PMID:
17765963
[PubMed - indexed for MEDLINE]
10.

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

ADVANCE Collaborative Group, Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F.

N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.

PMID:
18539916
[PubMed - indexed for MEDLINE]
Free Article
11.

Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

de Galan BE, Zoungas S, Chalmers J, Anderson C, Dufouil C, Pillai A, Cooper M, Grobbee DE, Hackett M, Hamet P, Heller SR, Lisheng L, Macmahon S, Mancia G, Neal B, Pan CY, Patel A, Poulter N, Travert F, Woodward M; ADVANCE Collaborative Group.

Diabetologia. 2009 Nov;52(11):2328-36. doi: 10.1007/s00125-009-1484-7. Epub 2009 Aug 18.

PMID:
19688336
[PubMed - indexed for MEDLINE]
12.

Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75).

Stratton IM, Cull CA, Adler AI, Matthews DR, Neil HA, Holman RR.

Diabetologia. 2006 Aug;49(8):1761-9. Epub 2006 May 31.

PMID:
16736131
[PubMed - indexed for MEDLINE]
13.
14.

Area-under-the-HbA1c-curve above the normal range and the prediction of microvascular outcomes: an analysis of data from the Diabetes Control and Complications Trial.

Maple-Brown LJ, Ye C, Retnakaran R.

Diabet Med. 2013 Jan;30(1):95-9. doi: 10.1111/dme.12004.

PMID:
22937915
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.

Akalin S, Berntorp K, Ceriello A, Das AK, Kilpatrick ES, Koblik T, Munichoodappa CS, Pan CY, Rosenthall W, Shestakova M, Wolnik B, Woo V, Yang WY, Yilmaz MT; Global Task Force on Glycaemic Control.

Int J Clin Pract. 2009 Oct;63(10):1421-5. doi: 10.1111/j.1742-1241.2009.02165.x.

PMID:
19769698
[PubMed - indexed for MEDLINE]
16.

The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.

Lind M, Olsson M, Rosengren A, Svensson AM, Bounias I, Gudbjörnsdottir S.

Diabetologia. 2012 Nov;55(11):2946-53. doi: 10.1007/s00125-012-2681-3. Epub 2012 Aug 16.

PMID:
22895807
[PubMed - indexed for MEDLINE]
17.

Intensive glucose control and cardiovascular outcomes in type 2 diabetes.

Macisaac RJ, Jerums G.

Heart Lung Circ. 2011 Oct;20(10):647-54. doi: 10.1016/j.hlc.2010.07.013. Epub 2010 Aug 31. Review.

PMID:
20807681
[PubMed - indexed for MEDLINE]
18.

Macrovascular and microvascular outcomes after beginning of insulin versus additional oral glucose-lowering therapy in people with type 2 diabetes: an observational study.

Hall GC, McMahon AD, Carroll D, Home PD.

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):305-13. doi: 10.1002/pds.2345. Epub 2012 Jan 23.

PMID:
22271442
[PubMed - indexed for MEDLINE]
19.

[Intensive blood glucose-lowering therapy: to which extent?].

Holleman F, de Vries JH, Hoekstra JB.

Ned Tijdschr Geneeskd. 2008 Nov 1;152(44):2381-4. Dutch.

PMID:
19055135
[PubMed - indexed for MEDLINE]
20.

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group.

Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.

PMID:
19515182
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk